Lorlatinib
Thông số
1454846-35-5Số CAS
813-704-5Số EC
(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrileTên IUPAC
C21H19FN6O2Công thức hóa học
406.4 g/molKhối lượng phân tử
Lorlatinib; 1454846-35-5; PF-06463922; Loratinib; Lorbrena; PF06463922; lorlatinibum; OSP71S83EU; 2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-; CHEBI:143117; DTXSID201027944; 2H-4,8-Methenopyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-; 7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile; (10R)-7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile; (10r)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15-Oxo-10,15,16,17-Tetrahydro-2h-8,4-(Metheno)pyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-Carbonitrile; (10r)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15-Oxo-10,15,16,17-Tetrahydro-2h-8,4-(Metheno)pyrazolo[4,3-H][2,5,11]benzoxadiazacyclotetradecine-3-Carbonitrile; (10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile; (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-4,8-methenopyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile; (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile; RefChem:56791; DTXCID401513511; (16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetraazatetracyclo(16.3.1.0^(2,6).0^(10,15))docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile; PF 06463922; MFCD28144520; (16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile; PF0643922; PF06463922(Lorlatinib); CHEMBL3286830; (R)-26-Amino-55-fluoro-11,4,7-trimethyl-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile; C21H19FN6O2; Lorviqua; UNII-OSP71S83EU; Lorlatinib (PF-06463922); Lorlatinib,PF-06463922; 4cli; 4clj; Lorbrena (TN); Lorlatinib (Standard); LORLATINIB [MI]; LORLATINIB [INN]; LORLATINIB [JAN]; Lorlatinib [USAN:INN]; LORLATINIB [USAN]; PFE-PKIS 10; LORLATINIB [WHO-DD]; Lorlatinib (JAN/USAN/INN); GTPL7476; orb1226235; orb1304578; LORLATINIB [ORANGE BOOK]; SCHEMBL15261807; SCHEMBL29352618; SCHEMBL29355669; EX-A828; GLXC-90386; BDBM50018830; HY-12215R; MSK174368; NSC780108; NSC800990; s7536; AKOS027250753; CCG-268718; CS-3983; DB12130; NSC-780108; NSC-800990; NCGC00386417-02; NCGC00386417-13; NCGC00386417-14; NCGC00386417-15; AC-30881; BP-44027; FP104236; HY-12215; NS00073142; D11012; F979308; L582694; BRD-K99879819-001-02-1; Q27285820; (10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetrad ecine-3-carbonitrile; (10R)-7-AMINO-12-FLUORO-2,10,16-TRIMETHYL-15-OXO-10,15,16,17-TETRAHYDRO-2H-4,8- METHENOPYRAZOLO(4,3-H)(2,5,11)BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILETên gọi khác
Sản phẩm chứa Lorlatinib
로비큐아정100밀리그램(롤라티닙)로비큐아정25밀리그램(롤라티닙)LORVIQUA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULALORVIQUA 100 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULALORVIQUA 25 mg, comprimé pelliculéLORVIQUA 100 mg, comprimé pelliculéLorlatinib - Biophore India Pharmaceuticals Pvt LtdLorlatinib - Sun Pharmaceutical Industries LimitedLorlatinib
